Hanx Biopharmaceuticals (Wuhan) Co Ltd

Company Profile

• Business description

  Hanx Biopharmaceuticals (Wuhan) Co Ltd is a biotech company with in-house capabilities in structural biology, translational medicine, and clinical development, focused on developing immunotherapeutic products. Its product pipeline comprises one Core Product and nine other pipeline candidates: three clinical-stage drug candidates focused on oncology, including its Core Product HX009 and Key Products HX301 and HX044; and seven preclinical-stage drug candidates, including an antibody drug conjugate, a bispecific antibody, and a monoclonal antibody for both autoimmune and oncology markets.

• Contact

  No. 1 Jiufeng 1st Road
  Building A8, Phase II, Bio-Innovation Park
  East Lake New Technology Development Zone
  Hubei
  Wuhan
  CHN

  T: +86 2765524978

  http://www.hanxbio.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2026

  Employees

  55